A Comparative Study of Driving Performance Among Adolescents With Autism Spectrum Disorder and Neurotypical Adolescents

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-17
SponsorHopital La Musse

About this trial

The primary objective of this study is to compare the number of driving errors made by novice adolescents (0-5 hours of driving instruction) with ASD to those made by neurotypical adolescents during a standardized driving simulator assessment. The secondary objectives of the study are to:

* Compare the visual strategies used by adolescents with ASD to those of neurotypical adolescents during a driving assessment on a simulator. * Compare the types of errors and driving performance (i.e., speed, reaction time, following distance, and braking distance) of adolescents with ASD to those of neurotypical adolescents during the driving simulator assessment. * Compare the driving performance of these two groups during a real-world road assessment using the TRIP scale. * Examine the consistency between driving performance measured in the simulator and that observed in real-world conditions for both groups. * Compare the anxiety levels of these two groups during driving tests on the simulator and on the road.

Eligibility criteria

Qualifiers

Adolescents aged 15 to 17,

With a confirmed diagnosis of ASD by a physician,

Without an intellectual disability, with a Fluid Reasoning Index (IRF) greater than 80,

Who have passed the written driver's license exam,

Disqualifiers

Adolescents with ADHD (attention-deficit/hyperactivity disorder) and/or ODD (oppositional defiant disorder) and/or IDD (intellectual disability) and/or SLI (specific language impairment) with associated comprehension difficulties,

Adolescents who already have a driver's license,

Adolescents currently taking driving lessons and/or with more than 5 hours of driving experience,

Adolescents who have suffered a head injury during childhood,

Trial design

Treatments tested in this trial

  • Assessment of executive functions and attention
  • Evaluation on a driving simulator
  • Evaluation on-road

Treatment groups

22 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Hopital La Musse

Lead sponsor

French Road Safety Delegation

Collaborator